The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO₂. It contains multiple copies of three enzymatic components: pyruvate dehydrogenase(E1), dihydrolipoamide acetyltransferase(E2) and lipoamide dehydrogenase(E3).

 

產(chǎn)品性質(zhì)

別名	DLAT; DLTA; E2; PBC; PDCE2
SwissProt ID	P10515
基因ID	1737
免疫原	A synthetic peptide of human Pyruvate Dehydrogenase E2.
緩沖液	50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
分子量	Calculated MW: 69 kDa; Observed MW：69 kDa
克隆類型	Monolonal Antibody
宿主	Rabbit
物種反應(yīng)	Human, Mouse, Rat, Hamster
推薦應(yīng)用	WB, ICC/IF, IP
純化方式	Affinity Purified

 

應(yīng)用

稀釋比 WB：1/500-1/1000; IF:1/50-1/200; IP:1/20

 

儲存條件

-25~-15℃保存

 

注意事項

1. 避免反復(fù)凍融。

2. 本產(chǎn)品僅作科研用途。

3. 為了您的安全和健康，請穿實驗服并佩戴一次性手套操作。

 

產(chǎn)品數(shù)據(jù)

Western blot

 

Immunocytochemistry

 

 

Ver.CN20230920